logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Ofsted warning over Pupil Premium

24 September 2012

The Pupil Premium is making little difference in raising the attainment of the poorest pupils, according to Ofsted.

The premium rose to £600 in 2012/13 for each pupil in care or on free school meals. However, only half of 117 schools surveyed said it had made a difference and a recent study shows that some 300,000 pupils eligible for claiming free school meals are not, for fear of being stigmatised.

Although schools are free to spend the extra funding as they see fit, from September 2012 onwards they will have to publish information about how they use it. Ofsted have urged schools to think carefully about how they use this money if the Pupil Premium is to have a future. In response, Russell Hobby of the NAHT stressed that schools are being put under increasing pressure to deliver results at the same time as their budgets are being cut.

Perhaps the important question is, is the Pupil Premium the best way to help disadvantaged pupils?

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up